A randomized controlled trial investigates the effects of empagliflozin on left ventricular recovery and cardiovascular outcomes in patients with ST-Elevation Myocardial Infarction (STEMI). The study contributes to understanding the potential benefits of empagliflozin in this patient population.
empagliflozin in stemi patients a randomized controlled trial on left ventricular recovery and cardiovascular outcomes
Original title: “Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes.”